×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Amello Jason

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
CADLCandel Therapeutics, Inc.Amello JasonChief Financial OfficerNov 28, 2023Option Exercise$0.9020,15318,138202,009Nov 30, 2023, 05:00 PM
CADLCandel Therapeutics, Inc.Amello JasonChief Financial OfficerDec 08, 2022Buy$1.693,1005,2393,100Dec 12, 2022, 04:25 PM
CADLCandel Therapeutics, Inc.Amello JasonChief Financial OfficerDec 09, 2022Buy$1.932,4684,7635,568Dec 12, 2022, 04:25 PM
AKBAAkebia Therapeutics, Inc.Amello JasonSVP, CFO & TreasurerFeb 28, 2020Sale$8.706,97660,691144,642Mar 02, 2020, 07:27 PM
AKBAAkebia Therapeutics, Inc.Amello JasonSVP, CFO & TreasurerApr 11, 2019Option Exercise$7.7013,148101,240118,618Apr 12, 2019, 04:00 PM
AKBAAkebia Therapeutics, Inc.Amello JasonSVP, CFO & TreasurerDec 12, 2018Option Exercise$8.9422,235198,78166,501Dec 13, 2018, 08:08 AM
AKBAAkebia Therapeutics, Inc.Amello JasonSVP, CFO & TreasurerNov 26, 2014Buy$13.221,00013,2205,000Dec 01, 2014, 06:13 AM
AKBAAkebia Therapeutics, Inc.Amello JasonSVP, CFO & TreasurerMar 25, 2014Buy$17.004,00068,0004,000Mar 27, 2014, 04:00 PM
ZIOPZIOPHARM ONCOLOGY INCAmello JasonExecutive Vice President & CFOMay 08, 2013Option Exercise$1.652,6234,32822,377May 14, 2013, 11:17 AM
GENZGENZYME CORPAmello JasonCorpContrllr,ChiefAccntOfficerApr 04, 2011Option Exercise$74.007,089524,5865,005Apr 06, 2011, 12:01 PM
GENZGENZYME CORPAmello JasonCorp Contrllr,ChiefAccntOfficrAug 31, 2010Option Exercise$58.2713,280773,8269,910Sep 02, 2010, 11:45 AM